Amarin suffers defeat over Vascepa patents

01-04-2020

Sarah Morgan

Amarin suffers defeat over Vascepa patents

Pavel Kapysh / Shutterstock.com

A US judge has opened the door to generic versions of heart disease drug Vascepa (icosapent ethyl), after invalidating Amarin’s key patents covering the drug. 


Amarin, Vascepa, ANDA, Dr Reddy's, Hikma Pharmaceuticals, patent infringement, patent obviousness, heart disease, generics

LSIPR